11 Of The Best Stocks Under $5 To Buy In April 2021!

Brent Davis - March 29, 2021

The Stock Dork is reader supported. We may earn a commission, at no additional cost to you if you buy products or signup for services through links on our site.

If you are a penny stock or small-cap stock trader, then you know it can be rough when you are trading the best stocks under $5

You know what I am trying to say, right? Micro-cap and small-cap stocks are as volatile as bottle rockets and trading them are not for the faint of heart. And neither are the best stocks under $5…

Now, if you are totally unfamiliar, here is a quick primer: penny stocks  can trade on the Over-the-Counter Bulletin Board exchange (OTC), a daily listing of the bid and ask prices for over-the-counter stocks, usually because they are too small to meet exchange-listing requirements.

OTC stocks are less regulated than stocks on the NYSE or Nasdaq, which means it can be difficult to know all the details about the company before you invest. To be frank, OTC stocks are not required to be transparent and often their press releases are hilarious exaggerations, so don’t believe everything you read.

One more thing to know, OTC stocks have less liquidity than exchange-traded securities along with lower trading volume, and larger spreads between the bid price and the ask price.

If we haven’t scared you off yet, it is because you know this: penny stocks and cheap stocks under $5 can mean mammoth returns or it can mean losing everything in minutes—it’s the Wild, Wild West. So, if you are ready to ride, here are the best five stocks under $5 right now.

As a note, not all the stocks below 5 trade on the OTC—see the exchange listing for details.

>> Breaking: The Top Growth Stocks For 2021 Revealed <<

Best Stocks Under $5 To Buy Now

Opko Health logo

Opko Health (NASDAQ: OPK)

Opko Health is a medical company based in Miami, Florida. They make pharmaceutical products as well as medical tests. They are a global company and are active in over 30 countries around the world. 

While Opko has many operations in their portfolio, the largest is BioReference Laboratories, which focuses on genetic testing. Some of Opko’s most successful products include a blood test for prostate cancer as well as a treatment for chemotherapy-induced nausea. 

Many investors have been excited about Opko Health stock this year. Their shares shot up by 169 percent over the course of 2020. Part of this is because BioReference pivoted to focus on COVID-19 PCR testing, which has been in high demand around the country. 

However, the company’s most recent earnings report had some investors a little concerned. Opko’s stock price dipped slightly after the report came out. Although their overall bottom line improved, their drug sales have slowed down and their operating expenses increased. 

This isn’t necessarily something to be concerned about in the long run, though. Opko’s revenue went up, and their EPS beat consensus estimates. If they’re able to keep this revenue growth up, it should balance out any fluctuation in drug sales. 

Additionally, Opko Health has announced that they will be part of the NY Forward Rapid Testing Program. This program aims to increase access to rapid COVID-19 tests. Opko has opened eight rapid testing locations throughout the US as a result. They’ve also recently committed to expanding COVID-19 testing for schools. 

The recent dip in Opko Health’s stock price actually makes it the perfect time to buy. This is a stock that definitely has the potential to pop above the $5 per share mark at some point this year. 

>> The 5 Growth Stocks To Buy For 2021 <<

Telefonica S.A (NYSE: TEF)

If you’re looking for a stock under $5 with a huge dividend yield, this is definitely one to keep in mind. Telefonica stock currently pays a huge 9.69 percent yield. 

Telefonica is a communications company based in Spain. They provide wireless service in Europe and Latin America. 

Although Telefonica did see a drop in revenue last year, their share price still looks relatively cheap. Right now, they have a price to earnings ratio of 15.85. This indicates that the stock is fairly affordable given the company’s current financial standing. 

There’s plenty of opportunity for growth in this industry. Many people have been relying on their phones for communication more than ever. With some companies switching to permanent remote work, it’s unlikely that demand for these services will go away.

Best Day Trading Stocks Under $5

Waitr logo

Waitr Holdings Inc. (NASDAQ: WTRH)

During the pandemic, food delivery and carryout services have skyrocketed in popularity. Wair is an up-and-coming company that offers both food delivery and carryout. Unlike many other food delivery services, they have flat delivery fees and can take group orders.

Right now, Waitr is only available in select cities in the southeastern United States, but they are expanding quickly. They work with many local business development groups to partner with small restaurants. Their focus on restaurants in rural areas separates them from other leading food delivery services, which tend to focus more on urban areas. 

Waitr stock is unique in that their share price actually went up when the pandemic hit. They had been struggling pre-pandemic due to high competition from other food delivery services. However, their stock price went up over the summer of 2020. They acquired another small delivery service, Bite Squad, which has helped them increase their delivery coverage. 

While their stock price has dropped off slightly from its peak in August, it has still remained relatively steady. At the end of February, Waitr announced they were partnering with Nextbite to provide delivery from virtual restaurants, or ‘ghost kitchens’. Ghost kitchens have become incredibly popular during the pandemic, which means there’s plenty of potential for the company to boost their revenue. 

Waitr currently has a market cap of $366.29 million. Revenue growth has been slow but steady over the course of their past few earnings reports. However, they were profitable for the last two quarters of 2020 – something very impressive for a company of this size. 

See Also: Joel Litman’s Hidden Alpha Review

Biotech Stocks Under $5

Aptinyx drug approach
Aptynix’s drug model

Aptinyx Inc. (NASDAQ: APTX)

Aptinyx is a pharmaceutical company based in Illinois. They have a focus on treating neurological disorders, and their drugs focus specifically on NMDA receptors. 

An ongoing study into an experimental Aptinyx PTSD treatment is showing promise mid-way through trials, according to an October 20 announcement. The 153-patient study found ‘statistically significant and clinically meaningful efficacy results with a favorable adverse event and tolerability profile.’

In other words, it’s looking good for NYX-783 early on. They have recently moved the drug into phase 2 of clinical trials. The drug has also received a fast track designation from the FDA, which means it could get approved very quickly if these tests are successful. 

PTSD is becoming an increasingly prevalent mental health issue in the developing world, and effective treatment options are scarce. Aptinyx might be onto something with NYX-783, and share prices could skyrocket if they get it right. 

In addition to their PTSD treatment, Aptinyx has two other drugs in the pipeline. NYX-2925 is currently in phase two of clinical trials and also has a fast track designation from the FDA. This drug will treat painful diabetic peripheral neuropathy and fibromyalgia. Their third drug, NYX-458, will treat the cognitive impairment associated with Parkinson’s disease. 

Aptinyx stock has had positive returns this year. Many analysts are feeling bullish on the stock moving forward into 2021, with some price targets as high as $10 per share. 

PDS Biotechnology (NASDAQ: PDSB)

This biotechnology company is working to develop treatments for some of the world’s most deadly cancers. They have several intriguing projects in their pipeline right now. 

Right now, their most promising candidate is a treatment for head and neck cancers as well as cervical cancer and other HPV-related malignancies. This product is currently in Phase II trials in partnership with the National Cancer Institute and Merck. 

They also have products in their pipeline that could treat prostate, breast, ovarian, and colorectal cancers, as well as melanoma. These products are still in the early stages of development. 

Perhaps more exciting is their development of a potential COVID-19 vaccine, as well as development for a universal flu vaccine and a tuberculosis vaccine. With new coronavirus variants emerging, it seems like there will be continuing demand for vaccines and treatments to keep the disease at bay. 

If this vaccine is eventually successful, it could result in a large boost for PDSB stock. Investors will want to keep a close eye on trial results for all of the company’s products.

>> These 5 Stocks Could Be Poised For Major Growth In 2021 <<

Best Tech Stocks Under $5

LiveXLive logo

LiveXLive Media (NASDAQ: LIVX)

LiveXLive‌ ‌Media‌ ‌is‌ ‌a‌ ‌digital‌ ‌media‌ ‌company‌ ‌that‌ ‌focuses‌ ‌on‌ ‌the‌ ‌acquisition,‌ ‌distribution,‌ ‌and‌ ‌
monetization‌ ‌of‌ ‌live‌ ‌music,‌ ‌internet‌ ‌radio,‌ ‌and‌ ‌podcasting,‌ ‌among‌ ‌other‌ ‌digital‌ ‌enterprises.‌ ‌
LiveXlive‌ ‌Media‌ ‌is‌ ‌also‌ ‌the‌ ‌force‌ ‌behind‌ ‌Slacker‌ ‌Radio,‌ ‌a‌ ‌moderately‌ ‌popular‌ ‌live‌ ‌music‌ ‌
streaming‌ ‌platform.‌ ‌ ‌

LiveXLiv‌e has had a good past year thanks to its focus on streaming music and podcasts. Given that live in-person music has tanked recently, their focus on streaming live music has put them in a unique niche and their share price is expected to continue to rise as more people look for ways to experience live music via streaming services.

The stock’s price has steadily increased over the last several months. The stock dipped slightly in the middle of February, but that means it could be the right time to buy before it goes back up again. Demand for music and podcast streaming isn’t going to go away anytime soon, as we are still several months away from hosting live events like concerts again. 

While LiveXLive isn’t profitable yet, their revenue numbers have consistently increased over the past several quarters. They are taking steps to diversify their operations, with both subscription and pay-per-view models to choose from. 

Limelight Networks (NASDAQ: LLNW)

Limelight Networks is a content delivery network company. This means they provide digital content and software delivery services for their clients. 

The pandemic has forced many employers to switch to working from home, and that isn’t going away anytime soon. This has been good for Limelight Networks, as there has been an increase in demand for content delivery services. 

The content delivery sector is a competitive one, and there have been some instances where Limelight hasn’t quite kept up in terms of earnings. Their most recent earnings report indicated that their yearly revenue growth was down and that they failed to turn a profit. 

This is why the stock’s price remains under $5 at the moment. However, digital content delivery is still relatively new, and the industry seems poised for a huge amount of growth over the next few decades. 

Additionally, Limelight has hired a new CEO in the past year. They have detailed a plan to adjust their pricing and increase their revenue over time. This could be a good investment if you’re looking for an affordable play in the content delivery space.

Also Read: Fast Fortune Club Review

Best Asian Stocks Under $5 

Tuniu Corp. (NASDAQ: TOUR)

It’s understandable why many investors have been wary of the travel industry this year. Pandemic-related shutdowns have grounded flights around the world, and people have been avoiding hotels and restaurants.

However, the Chinese market has been one of the first to start recovering. Tuniu is a Chinese digital travel agency that offers air and rail reservations, car rentals, tour packages, and more. 

This could be a good option for investors that are feeling bullish on the travel market and economic recovery in general. Their share price has gone up significantly since February, albeit with some fluctuations.

Dividend Stocks Under $5

Global Self Storage logo

Global Self Storage, Inc. (NASDAQ: SELF)

SELF is a REIT for self-storage properties that offer residential and commercial storage options. Global pays a dividend of $0.26, a great yield for a dividend stock under $5. Despite the recent economic turmoil, the self-storage sector industry seems secure. Low-interest rates will allow them to refinance debt, so SELF is in good shape.

Unfortunately, one reason for the growth is looming evictions. If people do lose homes, storage units often hold valuables that they can’t take with them to loved ones or downsized apartments.

During the pandemic, many people also chose to temporarily move out of their apartments in the city in order to stay with family. This meant that they relied on storage units to keep their property safe until they returned. As a result of the pandemic, it’s likely that people will continue to move around frequently. This bodes well for Global Self Storage. 

Global Self Storage has consistently performed well over the past several months. They saw a boost at the beginning of February, and we wouldn’t be surprised if they broke out of the $5 range soon. 

>> Want In On The Top 5 Growth Stocks For 2021? Our Top Picks Here <<

Best Stocks Under $5: Conclusion

Those are the names we consider hot stocks under $5 across markets right now. There will be lots of opportunities in the markets ahead but expect volatility. 

Want to buy a few of the stocks mentioned above? Check out Webull, a commission free brokerage. You can get free stocks just for signing up. You can check out Webull here

Did we miss any stocks you are making gains with? Let us know in the comments.


Brent Davis has been writing about the financial markets for 10 years and worked in research for the last five years at a Fortune 500 company. Brent's investing strategy is to buy high-quality companies and then let compounding do its thing.